Crinetics Pharmaceuticals, Inc. (CRNX) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$24,208
Total Return
142.08%
CAGR
19.34%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.59% |
| Median | +0.66% |
| Best | +85.23% |
| Worst | -40.78% |
| % of Windows Positive | 52.8% |
1-Year (252 Trading Days)
| Average | +30.03% |
| Median | +4.80% |
| Best | +236.20% |
| Worst | -47.31% |
| % of Windows Positive | 54.1% |
3-Year (756 Trading Days)
| Average | +116.60% |
| Median | +119.80% |
| Best | +237.50% |
| Worst | +8.92% |
| % of Windows Positive | 100.0% |
Risk Metrics
| Maximum Drawdown | -57.88% |
| Average Drawdown | -22.95% |
| Drawdown Duration | 355 Trading Days (Unrecovered) |
| Sortino Ratio | 1.00 |
| Calmar Ratio | 0.33 |
| CVaR (5%) | -7.38% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -14.61% (-42.57% ann.) | $1460.80 | $0.00 | $0.00 | $0.00 |
| 2025 | -8.96% | $895.75 | $0.00 | $0.00 | $0.00 |
| 2024 | +43.70% | +$4370.43 | $0.00 | $0.00 | $0.00 |
| 2023 | +94.43% | +$9442.62 | $0.00 | $0.00 | $0.00 |
| 2022 | -35.59% | $3558.61 | $0.00 | $0.00 | $0.00 |
| 2021 | +101.35% | +$10134.67 | $0.00 | $0.00 | $0.00 |
| 2020 | -43.76% | $4376.25 | $0.00 | $0.00 | $0.00 |
| 2019 | -16.34% | $1633.87 | $0.00 | $0.00 | $0.00 |
| 2018 partial | +22.36% (+55.89% ann.) | +$2235.82 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | July 18, 2018 – February 19, 2020 | -7.79% | -4.97% | $779.27 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -44.13% | -99.87% | $4412.73 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -13.64% | -21.02% | $1364.25 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +92.43% | +86.08% | +$9243.15 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -38.43% | -40.25% | $3843.34 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +185.05% | +75.97% | +$18504.57 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | -24.67% | -16.52% | $2467.31 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.